These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27684354)

  • 1. Cost-utility analysis of physician-pharmacist collaborative intervention for treating hypertension compared with usual care.
    Kulchaitanaroaj P; Brooks JM; Chaiyakunapruk N; Goedken AM; Chrischilles EA; Carter BL
    J Hypertens; 2017 Jan; 35(1):178-187. PubMed ID: 27684354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
    Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
    Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of two inexpensive postfracture osteoporosis interventions: results of a randomized trial.
    Majumdar SR; Lier DA; Leslie WD
    J Clin Endocrinol Metab; 2013 May; 98(5):1991-2000. PubMed ID: 23596140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.
    Camacho EM; Ntais D; Coventry P; Bower P; Lovell K; Chew-Graham C; Baguley C; Gask L; Dickens C; Davies LM
    BMJ Open; 2016 Oct; 6(10):e012514. PubMed ID: 27855101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental costs associated with physician and pharmacist collaboration to improve blood pressure control.
    Kulchaitanaroaj P; Brooks JM; Ardery G; Newman D; Carter BL
    Pharmacotherapy; 2012 Aug; 32(8):772-80. PubMed ID: 23307525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness Analysis of a Pharmacist-Led Medication Therapy Management Program: Hypertension Management.
    Schultz BG; Tilton J; Jun J; Scott-Horton T; Quach D; Touchette DR
    Value Health; 2021 Apr; 24(4):522-529. PubMed ID: 33840430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of Pharmacist Prescribing for Managing Hypertension in the United States.
    Dixon DL; Johnston K; Patterson J; Marra CA; Tsuyuki RT
    JAMA Netw Open; 2023 Nov; 6(11):e2341408. PubMed ID: 37921763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of pharmacist-physician collaborative care models vs usual care on time in target systolic blood pressure range in patients with hypertension: a payer perspective.
    Jay JS; Ijioma SC; Holdford DA; Dixon DL; Sisson EM; Patterson JA
    J Manag Care Spec Pharm; 2021 Dec; 27(12):1680-1690. PubMed ID: 34818090
    [No Abstract]   [Full Text] [Related]  

  • 10. Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis.
    Kaambwa B; Bryan S; Jowett S; Mant J; Bray EP; Hobbs FD; Holder R; Jones MI; Little P; Williams B; McManus RJ
    Eur J Prev Cardiol; 2014 Dec; 21(12):1517-30. PubMed ID: 23990660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis.
    Howard K; White S; Salkeld G; McDonald S; Craig JC; Chadban S; Cass A
    Value Health; 2010; 13(2):196-208. PubMed ID: 19878493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Costs and Cost-effectiveness of Collaborative Care for Adolescents With Depression in Primary Care Settings: A Randomized Clinical Trial.
    Wright DR; Haaland WL; Ludman E; McCauley E; Lindenbaum J; Richardson LP
    JAMA Pediatr; 2016 Nov; 170(11):1048-1054. PubMed ID: 27654449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of a Multicomponent Intervention for Hypertension Control in Low-Income Settings in Argentina.
    Zhang Y; Yin L; Mills K; Chen J; He J; Palacios A; Riviere AP; Irazola V; Augustovski F; Shi L
    JAMA Netw Open; 2021 Sep; 4(9):e2122559. PubMed ID: 34519769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of renal denervation therapy for the treatment of resistant hypertension in the UK.
    Gladwell D; Henry T; Cook M; Akehurst R
    Appl Health Econ Health Policy; 2014 Dec; 12(6):611-22. PubMed ID: 25086585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression.
    Pyne JM; Fortney JC; Tripathi SP; Maciejewski ML; Edlund MJ; Williams DK
    Arch Gen Psychiatry; 2010 Aug; 67(8):812-21. PubMed ID: 20679589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of home blood pressure telemonitoring and case management in the secondary prevention of cerebrovascular disease in Canada.
    Padwal RS; So H; Wood PW; Mcalister FA; Siddiqui M; Norris CM; Jeerakathil T; Stone J; Valaire S; Mann B; Boulanger P; Klarenbach SW
    J Clin Hypertens (Greenwich); 2019 Feb; 21(2):159-168. PubMed ID: 30570200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of a Physician-Pharmacist Collaboration Intervention to Improve Blood Pressure Control.
    Polgreen LA; Han J; Carter BL; Ardery GP; Coffey CS; Chrischilles EA; James PA
    Hypertension; 2015 Dec; 66(6):1145-51. PubMed ID: 26527048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the cost-effectiveness of pharmacist-managed anticoagulation service for older adults with atrial fibrillation in Singapore.
    Chua WB; Cheen HH; Kong MC; Chen LL; Wee HL
    Int J Clin Pharm; 2016 Oct; 38(5):1230-40. PubMed ID: 27461367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of Pharmacist-Led Deprescribing of NSAIDs in Community-Dwelling Older Adults.
    Sanyal C; Turner JP; Martin P; Tannenbaum C
    J Am Geriatr Soc; 2020 May; 68(5):1090-1097. PubMed ID: 32105355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.
    Rampersaud YR; Tso P; Walker KR; Lewis SJ; Davey JR; Mahomed NN; Coyte PC
    Spine J; 2014 Feb; 14(2):244-54. PubMed ID: 24239803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.